Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 3

2(33.3%)

6Total

N/A(4)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06225960Completed

Dorsal Root Ganglion Stimulation in Postherpetic Neuropathy

Role: collaborator

NCT06057350Not ApplicableRecruiting

Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR

Role: collaborator

NCT04111601Completed

BLI Based Adenoma Surveillance Strategy

Role: collaborator

NCT04884581Not ApplicableCompleted

Characterization of Colorectal Neoplasia

Role: lead

NCT02431663Phase 3Terminated

Ketamine in Refractory Convulsive Status Epilepticus

Role: collaborator

NCT02263144Unknown

Resect and Discard Extension to FICE of NIcE Classification

Role: collaborator

NCT02231385Not ApplicableUnknown

Acetic Acid Colonoscopy Enhancement Study

Role: collaborator

NCT02178033Not ApplicableUnknown

The Impact of Split Dose of Low-volume Polyethylene Glycol on Adenoma Detection Rate

Role: collaborator

NCT01399710Phase 3Completed

Impact of Computer-Aided Detection (CAD) as Second Reader in CT Colonography

Role: collaborator

All 9 trials loaded